<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pediatrics</journal-title>
</journal-title-group>
<issn pub-type="epub">2296-2360</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31032239</article-id>
<article-id pub-id-type="pmc">6470263</article-id>
<article-id pub-id-type="doi">10.3389/fped.2019.00136</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pediatrics</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Congenital Disorders of the Human Urinary Tract: Recent Insights From Genetic and Molecular Studies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Woolf</surname>
<given-names>Adrian S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/575618/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lopes</surname>
<given-names>Filipa M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ranjzad</surname>
<given-names>Parisa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roberts</surname>
<given-names>Neil A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/652043/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology Medicine and Health, School of Biological Sciences, University of Manchester</institution>, <addr-line>Manchester</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff2"><sup>2</sup><institution>Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre</institution>, <addr-line>Manchester</addr-line>, <country>United Kingdom</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Robert H. Mak, University of California, San Diego, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Kimberly Jean Reidy, Montefiore Medical Center, United States; Wai Cheung, University of California, San Diego, United States</p>
</fn>
<corresp id="c001">*Correspondence: Adrian S. Woolf <email>adrian.woolf@manchester.ac.uk</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Pediatric Nephrology, a section of the journal Frontiers in Pediatrics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>7</volume>
<elocation-id>136</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Woolf, Lopes, Ranjzad and Roberts.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Woolf, Lopes, Ranjzad and Roberts</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The urinary tract comprises the renal pelvis, the ureter, the urinary bladder, and the urethra. The tract acts as a functional unit, first propelling urine from the kidney to the bladder, then storing it at low pressure inside the bladder which intermittently and completely voids urine through the urethra. Congenital diseases of these structures can lead to a range of diseases sometimes associated with fetal losses or kidney failure in childhood and later in life. In some of these disorders, parts of the urinary tract are severely malformed. In other cases, the organs appear grossly intact yet they have functional deficits that compromise health. Human studies are beginning to indicate monogenic causes for some of these diseases. Here, the implicated genes can encode smooth muscle, neural or urothelial molecules, or transcription factors that regulate their expression. Furthermore, certain animal models are informative about how such molecules control the development and functional differentiation of the urinary tract. In future, novel therapies, including those based on gene transfer and stem cell technologies, may be used to treat these diseases to complement conventional pharmacological and surgical clinical therapies.</p>
</abstract>
<kwd-group>
<kwd>bladder</kwd>
<kwd>hydronephrosis</kwd>
<kwd>posterior urethral valves</kwd>
<kwd>prune belly syndrome</kwd>
<kwd>urofacial syndrome</kwd>
<kwd>ureter</kwd>
<kwd>vesicoureteric reflux</kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="118"></ref-count>
<page-count count="9"></page-count>
<word-count count="8208"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The urinary tract comprises the renal pelvis, the ureter, the urinary bladder and the urethra. The tract acts as a functional unit, first propelling urine from the kidney to the bladder, then storing it at low pressure inside the bladder which intermittently and completely voids urine through the urethra. In fact, it was the anatomist Andreas Vesalius who five centuries ago based on his careful autopsy studies (<xref ref-type="bibr" rid="B1">1</xref>) reasoned that the kidney, ureter and bladder form a single functional unit. Prior to this, authorities surmised that the kidneys somehow cleaned the blood but they did not necessarily appreciate their anatomical connection with the lower urinary tract.</p>
<p>Congenital diseases of the urinary tract can lead to a range of devastating diseases sometimes associated with fetal losses or kidney failure in childhood and later in life (<xref ref-type="bibr" rid="B2">2</xref>–<xref ref-type="bibr" rid="B4">4</xref>). In some of these disorders, parts of the urinary tract are absent, while in other cases the organs are present but are severely malformed. In yet other cases, the organs appear grossly intact yet they have congenital functional deficits that can compromise health. Human studies are beginning to indicate monogenic causes for some of these diseases, as reviewed in the last decade (<xref ref-type="bibr" rid="B5">5</xref>). Here, we present an update of several of the implicated genes which encode smooth muscle, neural or urothelial structural, and functional molecules, or master transcription factors that regulate their expression. Furthermore, certain animal models are informative about how such molecules control the development and functional differentiation of the urinary tract, and we have alluded to several of them here.</p>
<p>This review does not focus on the detailed anatomy and developmental biology of the kidney and urinary tract, and for reviews of these aspects the reader is referred to other literature (<xref ref-type="bibr" rid="B6">6</xref>–<xref ref-type="bibr" rid="B8">8</xref>). Furthermore, our focus on the urinary tract does not cover the genetic bases of human kidney malformations <italic>per se</italic> and for this specific topic the reader is directed to other reviews (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Lastly, although the term ‘congenital anomalies of the kidney and urinary tract', or CAKUT, might be used to include some of the entities we discuss here, we have elected not to use this term because its all-encompassing remit lacks the focus that is required here on the ureter and bladder. Finally, it is important to recognize that factors that perturb embryonic milieu may also adversely impact on urinary tract development: these include maternal diet, vitamin availability, levels of blood glucose and <italic>in vitro</italic> fertilization: again, these aspects are considered elsewhere (<xref ref-type="bibr" rid="B11">11</xref>–<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p><xref ref-type="table" rid="T1">Table 1</xref> lists the prevalence of several of the congenital urinary tract diseases that will be discussed, and <xref ref-type="table" rid="T2">Table 2</xref> list some of the genes implicated in their pathogenesis.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Prevalences of human congenital urinary tract diseases.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Urinary tract disease</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Prevalence</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bladder exstrophy</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.002% births</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B15">15</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Megabladder</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.30–0.06% in first trimester</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B16">16</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Posterior urethral valves</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.01% births</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B17">17</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Primary non-syndromic vesicoureteric reflux</td>
<td align="left" colspan="1" rowspan="1" valign="top">Estimated 1–10% in young children</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B18">18</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Prune belly syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.004% live births</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B19">19</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ureteropelvic junction obstruction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up to 0.4% of newborns</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B20">20</xref>–<xref ref-type="bibr" rid="B22">22</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Urofacial syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prevalence unknown but around 150 postnatal cases reported</td>
<td align="center" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B23">23</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Genes implicated in congenital disorders of the human urinary tract.</p>
</caption>
<table frame="hsides" rules="groups">
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>ACTA2</italic> encoding the smooth muscle contractile protein alpha smooth muscle actin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>ACTG2</italic> encoding the smooth muscle contractile protein γ2-actin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>BNC2</italic> encoding basonuclin 2, a zinc finger containing protein implicated in epithelial maturation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>CHRM3</italic> encoding M3, the main acetylcholine receptor in detrusor smooth muscle</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>HNF1B</italic> encoding a transcription factor widely expressed in renal tract epithelia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>HPSE2</italic> encoding heparanase 2, a protein that may modulate growth factor signaling in bladder nerves</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>ISL1</italic> encoding a transcription factor that may be involved in formation of the bladder and urethra</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>LRIG2</italic> encoding leucine-rich-repeats and immunoglobulin-like-domains 2 that may modulate growth factor signaling in bladder nerves</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>MYH11</italic> encoding the smooth muscle contractile protein called myosin heavy chain 11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>MYLK</italic> encoding myosin light chain kinase that modifies myosin in smooth muscle cells</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>PAX2</italic> encoding a transcription factor widely expressed in the developing ureter and kidney</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>TBX18</italic> encoding a transcription factor that affects morphogenesis of the ureter</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>TNXB</italic> encoding an extracellular matrix protein found in the urinary tract</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>TSHZ3</italic> encoding a transcription factor that modulates smooth muscle differentiation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>UPKIIIA</italic> encoding a member of the uroplakin family that water-proofs the urothelium</td>
</tr>
</table>
</table-wrap>
</sec>
<sec id="s2">
<title>Genetic Studies of Vesicoureteric Reflux, a Common Urinary Tract Malformation</title>
<p>Certain types of urinary tract malformation are thought to be common, such as primary non-syndromic vesicoureteric reflux (VUR). The term describes the retrograde trajectory of urine from the bladder into the upper urinary tract that is neither caused by bladder outflow obstruction (i.e., “primary”) nor associated with malformations outside the renal tract (i.e., “non-syndromic”). The precise prevalence of this condition is uncertain because large asymptomatic populations have not been screened by cystography. The prevalence, however, has been estimated to be as high as 10% percent in babies and young children (<xref ref-type="bibr" rid="B18">18</xref>). Prospective studies have shown that milder degrees of VUR usually spontaneously regress during childhood (<xref ref-type="bibr" rid="B24">24</xref>). Families with multiple members affected by VUR are recognized yet may not have been exhaustively investigated by cystography. This makes it challenging to track VUR within families. All these aspects make it challenging to undertake genetic studies in primary VUR. Indeed, numerous studies have undertaken genetic linkage or association analyses and indicated various loci as candidates for primary VUR (<xref ref-type="bibr" rid="B25">25</xref>–<xref ref-type="bibr" rid="B30">30</xref>). Unfortunately, there has been little inter-study uniformity in the loci. Reasons could be that the studies were underpowered, primary VUR is genetically heterogenous, and its modes of inheritance are varied. The largest published study to date (<xref ref-type="bibr" rid="B31">31</xref>), using parametric linkage analysis of 1,062 affected individuals from 460 families under a dominant model, identified a single region on chromosome 10q26. The locus contains 69 genes, yet sequencing them failed to reveal likely pathogenic variants in their coding regions. One explanation could be that the region contains mutations in yet-to-be defined non-coding regulatory regions of genes that direct ureter development. Other studies have pointed to variants in specific genes. Two such studies (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>) implicated variants of <italic>ROBO2</italic> in primary VUR, and mutations in this gene do cause ureter malformations in mice (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Others, however, were unable to confirm the observations in other primary VUR populations (<xref ref-type="bibr" rid="B35">35</xref>). A similar story of non-replication (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>) applies to variants in the gene called <italic>RET</italic> that encodes a growth factor receptor that drives growth of the embryonic ureter rudiment (<xref ref-type="bibr" rid="B38">38</xref>). The uroplakins are a family of proteins that form heterodimers that coat the apical surface of the urothelium that lines the renal pelvis, the ureter and the bladder (<xref ref-type="bibr" rid="B39">39</xref>). They are thought to confer water-proofing properties and so prevent the egress of urine back into the body. Mice with homozygous mutations of <italic>uroplakin IIIa</italic> (UpkIIIA) or <italic>UpkII</italic> have severe urinary tract malformations including VUR and hydronephrosis (<xref ref-type="bibr" rid="B39">39</xref>), and when the zebrafish homolog called upkIII was experimentally knocked-down, embryonic kidney tubule epithelia showed mislocalisation of proteins including the Na<sup>+</sup>/K<sup>+</sup>-ATPase (<xref ref-type="bibr" rid="B40">40</xref>). Rare individuals with heterozygous predicted pathogenic <italic>UPKIIIA</italic> mutations have been reported (<xref ref-type="bibr" rid="B41">41</xref>–<xref ref-type="bibr" rid="B43">43</xref>) and some have ureter malformations, including VUR. In contrast, when large populations with primary non-syndromic VUR were studied, <italic>UPK</italic> mutations could not be identified (<xref ref-type="bibr" rid="B44">44</xref>). One explanation could be that <italic>UPK</italic> mutations are rarely compatible with life and so would not be expected to be found in generally healthy individuals with VUR.</p>
</sec>
<sec id="s3">
<title>Genetic Breakthroughs in Syndromic Congenital Disorders of the Human Urinary Tract</title>
<p>If discovering specific genetic causes of primary non-syndromic VUR has so far proved elusive, much more progress has been made in defining causative genes in syndromic congenital disorders of the urinary tract i.e., those where there is associated disease outside the urinary tract. In this respect, perhaps the most convincing gene implicated thus far in human primary VUR is <italic>TNXB</italic> that encodes an extracellular matrix protein that is expressed in the urinary tract (<xref ref-type="bibr" rid="B45">45</xref>). A heterozygous variant was found to track with VUR in a large family, and cell biology experiments showed that the variant altered cell motility in cultured fibroblasts. Furthermore, rare <italic>TNBX</italic> missense variants were found in certain VUR families in another study (<xref ref-type="bibr" rid="B46">46</xref>). Close inspection of affected individuals revealed that some have joint hypermobility and, of note, <italic>TNBX</italic> loss of function mutations had previously been reported in Ehlers-Danlos syndrome (<xref ref-type="bibr" rid="B47">47</xref>). Thus, these families with VUR and <italic>TNXB</italic> variants might be considered to have a forme-fruste on the full-blown Ehlers-Danlos syndrome that has been reported to be associated with urinary bladder diverticula (<xref ref-type="bibr" rid="B48">48</xref>). Similar observations have been made for <italic>PAX2</italic>, a gene that encodes a transcription factor which is widely expressed in the developing kidney and the urinary tract, and also the optic nerve. Mice with heterozygous mutations of <italic>Pax2</italic> have congenitally small kidneys and can have VUR (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). Rare individuals born with malformed kidneys, sometimes accompanied by VUR, have been found to carry heterozygous <italic>PAX2</italic> mutations (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). A subset of such individuals also have optic nerve malformations (<xref ref-type="bibr" rid="B51">51</xref>), so fulfilling all the criteria of the full-blown ‘renal coloboma syndrome'. Again, however, when <italic>PAX2</italic> was sequenced in larger populations with primary non syndromic VUR, mutations could not be identified (<xref ref-type="bibr" rid="B53">53</xref>). In the remainder of this review, we will focus on several other rare diseases with defined genetic causes.</p>
</sec>
<sec id="s4">
<title>Prune Belly Syndrome</title>
<p>Prune belly syndrome describes a constellation of signs present from the antenatal period featuring a massively distended bladder that fails to empty fully, and overlying abdominal wall muscles that are thinner than normal (<xref ref-type="bibr" rid="B54">54</xref>). It nearly always occurs in boys when the signs include undescended testicles. For this condition, the term “sequence” may be more accurate than “syndrome” because the abdominal features could be secondary to the massive bladder distention. The prevalence of prune belly syndrome has been calculated as being 3.8 per 100,000 live births (<xref ref-type="bibr" rid="B19">19</xref>). Before birth, the syndrome is one cause of “megabladder,” a massively dilated bladder, a phenotype with a first trimester prevalence of 1:330–1670 (<xref ref-type="bibr" rid="B16">16</xref>). From review of the detailed phenotypes (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>), prune belly syndrome is likely to have more than one etiology. On histology, some affected individuals have physical blockade of the urethra, for example with urethral agenesis or valves, with a hypertrophied bladder wall. Others, by contrast, have an overtly patent urethra, sometimes with a poorly developed prostatic bed and their bladders can contain disorganized muscle bundles and prominent connective tissue. These two categories would therefore, respectively have either “anatomic” or “functional” bladder obstruction. Contraction of detrusor smooth muscle in the body of the bladder is the driver for urinary voiding, and the neural signal to contract is acetylcholine that is released by parasympathetic autonomic nerves and which binds to the M3 muscarinic receptor. Homozygous, putative loss-of-function mutations, of <italic>CHRM3</italic> have been reported in a family with several males affected by a prune belly-like disease (<xref ref-type="bibr" rid="B57">57</xref>). <italic>CHRM3</italic> codes for M3 and the large floppy bladders in this family strikingly resemble the phenotype reported in male homozygous <italic>Chrm3</italic> mutant mice (<xref ref-type="bibr" rid="B58">58</xref>). M3 also mediates pupillary contraction to light and the above family showed defects in this reflex (<xref ref-type="bibr" rid="B57">57</xref>). A family with a phenotypically similar bladder and eye syndrome have been described but genetic tests were reported to be unrevealing (<xref ref-type="bibr" rid="B59">59</xref>). Of note, M3 is present in the embryonic bladder urothelium, as well as in smooth muscle, indicating that it may have other, as yet undefined, roles in the developing urinary tract (<xref ref-type="bibr" rid="B57">57</xref>).</p>
<p>Other individuals found to have massively dilated bladders yet no anatomical outflow obstruction carry mutations of genes that encode smooth muscle contractile proteins, or other molecules needed for their functionality. Indeed, mutations of the following genes have been identified in either prune belly or the overlapping disease called megacystis microcolon intestinal hypoperistalsis syndrome: <italic>ACTA2</italic>, encoding α-smooth muscle actin (<xref ref-type="bibr" rid="B60">60</xref>); <italic>ACTG2</italic>, encoding γ2 smooth muscle actin (<xref ref-type="bibr" rid="B61">61</xref>); <italic>MYH11</italic>, encoding a smooth muscle heavy chain protein (<xref ref-type="bibr" rid="B62">62</xref>); and <italic>MYLK</italic> encoding myosin light chain kinase that modifies myosin chains in smooth muscle cells (<xref ref-type="bibr" rid="B63">63</xref>). Another candidate gene in relation to myogenic failure is <italic>MYOCD</italic> that encodes a transcription-related protein needed for expression of smooth muscle contractile proteins (<xref ref-type="bibr" rid="B64">64</xref>–<xref ref-type="bibr" rid="B66">66</xref>). A study that used microarrays to seek copy number variants in 34 cases of prune belly syndrome found that one carried a deletion of a locus encompassing <italic>MYOCD</italic> (<xref ref-type="bibr" rid="B67">67</xref>). Finally, heterozygous whole gene deletions of <italic>HNF1B</italic> have been reported in rare patients with prune belly syndrome (<xref ref-type="bibr" rid="B68">68</xref>). The gene codes for hepatocyte nuclear factor 1B transcription factor that is widely expressed in epithelia in the developing renal tract (<xref ref-type="bibr" rid="B69">69</xref>). On the other hand, while heterozygous mutations of <italic>HNF1B</italic> are well-recognized to cause diverse kidney malformation, these patients do not have prune belly syndrome (<xref ref-type="bibr" rid="B70">70</xref>). Moreover, another study found that, while a patient with prune belly syndrome carried a missense variant of <italic>HNF1B</italic>, this did not affect the transactivation functional of the encoded protein (<xref ref-type="bibr" rid="B71">71</xref>). A further caveat is that whole gene deletions of <italic>HNF1B</italic> may also extend to adjacent genes (<xref ref-type="bibr" rid="B68">68</xref>) so that the final phenotype may not be ascribed to <italic>HNF1B</italic> itself.</p>
</sec>
<sec id="s5">
<title>Urofacial Syndrome</title>
<p>Urofacial, or Ochoa, syndrome (UFS) is characterized by a bladder in which the detrusor contracts against an incompletely dilated bladder outflow tract, with the result being high hydrostatic pressures within the bladder yet incomplete voiding (<xref ref-type="bibr" rid="B23">23</xref>). It is therefore another example of functional bladder outlet obstruction. Complications include high pressure VUR, ascending bacterial infection, pyelonephritis and renal failure. Affected individuals also have a characteristic grimace when smiling, and a neurogenic basis for this bladder disease has long been surmised (<xref ref-type="bibr" rid="B72">72</xref>). The prevalence of the syndrome is not known but at around 150 cases, mostly children, have been reported in the medical literature (<xref ref-type="bibr" rid="B23">23</xref>). Inherited in an autosomal dominant manner, a subset of affected families have biallelic mutations of <italic>HPSE2</italic> (<xref ref-type="bibr" rid="B73">73</xref>–<xref ref-type="bibr" rid="B77">77</xref>) encoding a protein called heparanase 2 that inhibits the enzymatic activity of heparanase (<xref ref-type="bibr" rid="B78">78</xref>) that can release growth factors sequestered on matrix molecules called glycosaminoglycans. Other families with UFS instead have biallelic mutations of <italic>LRIG2</italic> (<xref ref-type="bibr" rid="B79">79</xref>–<xref ref-type="bibr" rid="B81">81</xref>), that encodes a putative plasma membrane protein called leucine-rich-repeats and immunoglobulin-like-domains 2. This protein is thought to mediate growth factor signaling (<xref ref-type="bibr" rid="B82">82</xref>), in part by analogy to other better studied LRIG family members (<xref ref-type="bibr" rid="B83">83</xref>). Experimental knockdown of the Xenopus hpse2 homolog in embryos causes disorganized peripheral motor nerves (<xref ref-type="bibr" rid="B84">84</xref>) and, in mouse developing urinary tracts, both heparanase 2 and LRIG2 can be immunodetected in pelvic ganglia, the structures that send autonomic nerves into the bladder (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B81">81</xref>). Moreover, both proteins can be detected in nerves growing into normal human fetal bladders (<xref ref-type="bibr" rid="B79">79</xref>). Mice that have homozygous mutations for either <italic>Hpse2</italic> (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B85">85</xref>) or <italic>Lrig2</italic> (<xref ref-type="bibr" rid="B81">81</xref>) have impaired bladder emptying. Moreover, these mice have abnormal patterns of bladder nerves, with a depletion around the outflow tract, and an overabundance in the body of the bladder (<xref ref-type="bibr" rid="B79">79</xref>). Both mutants also show downregulated levels of bladder transcripts encoding neuronal nitric oxide synthase (<xref ref-type="bibr" rid="B81">81</xref>), a protein known to mediate bladder outflow dilatation (<xref ref-type="bibr" rid="B86">86</xref>). Thus, evidence is accumulating that UFS is a peripheral neuropathy of the urinary bladder, and it is hoped that the definition of aberrant neurobiology will suggest logical therapies for this devastating disease.</p>
</sec>
<sec id="s6">
<title>Congenital Hydronephrosis Caused by Primary Ureter Malformations</title>
<p>Molecularly upstream of myocardin is another transcription factor called teashirt-3, encoded by <italic>TSHZ3</italic> (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B87">87</xref>). TSHZ3 is normally expressed in mesenchymal cells at the top of the embryonic ureter that are differentiating into smooth muscle cells (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B88">88</xref>). Homozygous mutant <italic>Tshz3</italic> mice fail to develop ureteric muscle in this location and, unable to peristalsis in this location, have hydronephrotic functionally obstructed ureters (<xref ref-type="bibr" rid="B64">64</xref>). Of note, humans with heterozygous deletions of <italic>TSHZ3</italic> can be born with malformed ureters, and these individuals also suffer from an autism-like disorder because the same gene is expressed in, and drives the functional differentiation of, brain cortical neurons (<xref ref-type="bibr" rid="B89">89</xref>). Other transcription factors regulate smooth muscle differentiation in the ureter. A preliminary study suggested that TSHZ3 interacts with SOX9 (<xref ref-type="bibr" rid="B87">87</xref>) and in humans mutations of the latter gene cause a multiorgan malformation syndrome called campomelic dysplasia (<xref ref-type="bibr" rid="B90">90</xref>) featuring sex reversal and hydroureter (<xref ref-type="bibr" rid="B91">91</xref>). Similarly, TBX18 is a transcription factor transiently expressed in mesenchymal cells of the embryonic ureter around the urothelium (<xref ref-type="bibr" rid="B92">92</xref>). Homozygous mutant <italic>Tbx18</italic> mice form fibroblast-like cells rather than normal smooth muscle in this location (<xref ref-type="bibr" rid="B92">92</xref>). Humans with heterozygous <italic>TBX18</italic> pathogenic variants have been reported (<xref ref-type="bibr" rid="B93">93</xref>) who have ureteropelvic junction obstruction and hydronephrosis, a phenotype with a postnatal prevalence of up to 0.3–0.4% newborns (<xref ref-type="bibr" rid="B20">20</xref>–<xref ref-type="bibr" rid="B22">22</xref>). Based on cell culture experiments, it is also possible that the same gene is required to differentiation of pacemaker cells in the ureter (<xref ref-type="bibr" rid="B94">94</xref>).</p>
</sec>
<sec id="s7">
<title>Posterior Urethral Valves</title>
<p>Posterior urethral valves, a disease confined to males, is a common cause of lower urinary tract obstruction detected by antenatal ultrasound screening. When accompanied by oligohydramnios and kidney damage, neonatal survival is compromised and not significantly improved by fetal vesicoamniotic shunting (<xref ref-type="bibr" rid="B4">4</xref>). The prevelance of posterior urethral valves has been calculated to be 1 in 7,800 live births (<xref ref-type="bibr" rid="B17">17</xref>). Although generally a sporadic disease, families have been reported with more than one sibling affected (<xref ref-type="bibr" rid="B95">95</xref>). Moreover, monozygotic vs. dizygotic twin studies are consistent with a genetic component (<xref ref-type="bibr" rid="B96">96</xref>). Currently, however, putative genetic bases for posterior urethral valves remain elusive. Two studies (<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B98">98</xref>) have reported on a variety of copy number variants in patients with posterior urethral valves but a convincing pattern or stronger evidence of pathogenicity yet to emerge for these. Of note, a preliminary study reported multiple members over three generations affected by anatomical uretral obstruction who carried a heterozygous non-sense mutation of <italic>BNC2</italic> (<xref ref-type="bibr" rid="B99">99</xref>). This gene codes for basonuclin 2 a zinc finger protein that is expressed in the embryonic urethra (<xref ref-type="bibr" rid="B99">99</xref>). Furthermore, experimental downregulation of the homologous gene in zebrafish caused malformation of the distal part of the embryonic urinary tract (<xref ref-type="bibr" rid="B99">99</xref>), and mutant <italic>Bnc2</italic> mice have malformed urethras (<xref ref-type="bibr" rid="B100">100</xref>).</p>
</sec>
<sec id="s8">
<title>Bladder Exstrophy</title>
<p>In classic bladder extrophy, the front part of the bladder is open, and this is considered an intermediate severity disorder in the spectrum of mid-line diseases that span epispadias and cloacal exstrophy. The prevalence has been measured as 2.1 per 100,000 births, with a positive correlation with maternal age (<xref ref-type="bibr" rid="B15">15</xref>). Genetic association studies have implicated variation in the <italic>ISL1</italic> locus in classic bladder extrophy, yet pathogenic variants in the <italic>ISL1</italic> coding region have not been proven (<xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B102">102</xref>). Another idea is that the association with the ISL1 locus indicates functional variation of a non-coding genomic region that affects ISL1 expression but this hypothesis has yet to be proven (<xref ref-type="bibr" rid="B103">103</xref>). <italic>ISL1</italic> is a transcription factor known to be expressed in the region of the forming mouse bladder (<xref ref-type="bibr" rid="B102">102</xref>). Mutant <italic>Isl1</italic> mice have an epispadias-like phenotype, and in normal development the encoded transcription factor induces bone morphogenetic factor 4 (BMP4) mediated remodeling of mesenchymal cells (<xref ref-type="bibr" rid="B104">104</xref>). Of note, BMP4 is also immunodetected in the walls of human embryonic bladders (<xref ref-type="bibr" rid="B105">105</xref>) and other experiments suggest its expression is under the control of sonic hedgehog, a growth factor secreted by embryonic urothelium (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B105">105</xref>). Several studies have sought copy number variants in the bladder extrophy-epispadias spectrum, and a small but statistically significant subset of affected individuals have duplication of chromosome 22q11.2 (<xref ref-type="bibr" rid="B106">106</xref>–<xref ref-type="bibr" rid="B108">108</xref>). The critical region contains numerous genes expressed in the developing kidney and urinary tract including <italic>CRKL</italic>, encoding a transforming protein kinase, that itself has been implicated as causing the kidney malformation found in DiGeorge syndome (<xref ref-type="bibr" rid="B109">109</xref>). In this context, however, the gene dosage is reduced (i.e., “haploinsufficiency”) rather than amplified and, moreover, the DiGeorge syndrome does not feature bladder extrophy.</p>
</sec>
<sec id="s9">
<title>Conclusions and Novel Therapeutic Perspectives</title>
<p>As discussed above, the genetic breakthroughs in this field of human disease have come from investigating families with rare congenital urinary tract diseases. Here, studies are indicating that the implicated genes encode smooth muscle, neural or urothelial molecules, or master transcription factors that regulate their expression. To date, however, variants in these same genes do not appear to explain the more common human non-syndromic urinary tract malformations such as primary VUR. Whole exome sequencing, a technology that seeks variants in the protein coding regions of all genes, is being applied to seek likely pathogenic mutation in clinical cohorts, including adult with chronic kidney disease (<xref ref-type="bibr" rid="B110">110</xref>) and children born with a range kidney malformations (<xref ref-type="bibr" rid="B111">111</xref>). Such research exercises have yielded useful genetic information in 10–14% of cases tested.</p>
<p>In future, it may be informative to apply these technologies to groups of patients born with the urinary tract malformations described in the current review. It is important to remember, however, that mutations may not be the only explanation for congenital urinary tract malformations. As alluded to in the <italic>Introduction</italic>, the fetal environment can be modified by alterations in maternal diet or the presence of maternal disease, such as diabetes mellitus (<xref ref-type="bibr" rid="B11">11</xref>–<xref ref-type="bibr" rid="B14">14</xref>). These non-genetic changes might themselves perturb the normal trajectory of organogenesis. Along the same lines, epigenetic alternations, such as DNA methylation, may profoundly affect expression of renal genes and thus impact on the propensity to disease. For example, such a mechanism has recently been implicated in gene expression of aging human kidneys (<xref ref-type="bibr" rid="B112">112</xref>) and there exists preliminary evidence that similar mechanisms may be operative in human renal malformations (<xref ref-type="bibr" rid="B113">113</xref>).</p>
<p>At least for the rare syndromes discussed in this review, as the genetics and pathobiology becomes defined, it is possible to begin to envisage smart biological therapies for these diseases to complement conventional pharmacological and surgical clinical interventions. Indeed, gene therapy, for example mediated by viral vectors, may offer promise. In a recent striking breakthrough, babies with spinal muscular atrophy 1 caused by <italic>survival motor neuron 1</italic> mutations were intravenously administered adeno-associated virus (AAV) that transduced <italic>SMN1</italic>, the gene that is at fault in this disease. By 20 months the infants were alive and developing well, whereas untreated individuals would have been expected to have died or alive but severely paralyzed (<xref ref-type="bibr" rid="B114">114</xref>). The AAV viral vector used is a non-pathogenic virus that rarely integrates into the host genome, and numerous trials with AAV vectors have been registered for monogenic and other disorders. Of note, specific AAV serotypes can deliver reporter genes into developing mouse renal tracts after maternal, embryonic and neonatal administration; proven targets include kidneys (AAV9), urinary bladders (AAV9) and autonomic and dorsal root and gut ganglia (AAV8 and 9) (<xref ref-type="bibr" rid="B115">115</xref>–<xref ref-type="bibr" rid="B118">118</xref>). The urinary tract diseases with defined genetic bases, described in this review, meet key criteria for being suitable to be treated with viral gene delivery. Current management for these diseases only attempts to control symptoms, for example with physical bladder drainage, rather than cure the disease process. The diseases are genetically defined, with well-defined links between the normally encoded proteins and disease phenotypes. Moreover, there are phenotypically faithful genetic mouse models on which to test novel biological treatments as first steps to the clinic. The selection of patients who may benefit from novel therapies would, however, have to be highly judicious because the presence of a mutant gene may not in itself be sufficient to generate a clinically significant malformation. This is because the severity of disease in an individual may theoretically be altered by as-yet poorly defined modifying genes, epigenetic changes, and alterations of the fetal environment.</p>
</sec>
<sec id="s10">
<title>Author Contributions</title>
<p>All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> We acknowledge grant support from: Medical Research Council project grant MR/L002744/1 (AW); Horizon 2020 Marie Skłodowska-Curie Actions Initial Training Network (942937) RENALTRACT (AW, FL); Newlife Foundation (AW); Kidney Research UK Non-Clinical Training Fellowship (N.A.R.) and project grant RP_018_20170302 (NR, AW). Histology Core Facility equipment was purchased with grants from the University of Manchester Strategic Fund. Human embryonic material was provided by the Joint MRC and Wellcome Trust (MR/R006237/1) Human Developmental Biology Resource (<ext-link ext-link-type="uri" xlink:href="http://www.hdbr.org">www.hdbr.org</ext-link>). Open Access charges will be requested from the University of Manchester library.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Androutsos</surname><given-names>G</given-names></name></person-group>. <article-title>The urology in the anatomical plates of Andreas Vesalius (1514–1564)</article-title>. <source/>Prog Urol. (<year>2005</year>) <volume>15</volume>:<fpage>544</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">16097171</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerecuk</surname><given-names>L</given-names></name><name><surname>Schreuder</surname><given-names>MF</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name></person-group>
<article-title>Human renal tract malformations: perspectives for Nephrologists</article-title>. <source/>Nat Clin Pract Nephrol. (<year>2008</year>) <volume>4</volume>:<fpage>312</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1038/ncpneph0807</pub-id><pub-id pub-id-type="pmid">18446149</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capone</surname><given-names>VP</given-names></name><name><surname>Morello</surname><given-names>W</given-names></name><name><surname>Taroni</surname><given-names>F</given-names></name><name><surname>Montini</surname><given-names>G</given-names></name></person-group>. <article-title>Genetics of congenital anomalies of the kidney and urinary tract: the current state of play</article-title>. <source/>Int J Mol Sci. (<year>2017</year>) <volume>18</volume>:<fpage>E796</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18040796</pub-id><pub-id pub-id-type="pmid">28398236</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>RK</given-names></name><name><surname>Malin</surname><given-names>GL</given-names></name><name><surname>Quinlan-Jones</surname><given-names>E</given-names></name><name><surname>Middleton</surname><given-names>LJ</given-names></name><name><surname>Hemming</surname><given-names>K</given-names></name><name><surname>Burke</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial</article-title>. <source/>Lancet. (<year>2013</year>) <volume>382</volume>:<fpage>1496</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60992-7</pub-id><pub-id pub-id-type="pmid">23953766</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Stuart</surname><given-names>HM</given-names></name><name><surname>Newman</surname><given-names>WG</given-names></name></person-group>. <article-title>Genetics of human congenital urinary bladder disease</article-title>. <source/>Pediatr Nephrol. (<year>2014</year>) <volume>29</volume>:<fpage>353</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-013-2472-1</pub-id><pub-id pub-id-type="pmid">23584850</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Davies</surname><given-names>JA</given-names></name></person-group>. <article-title>Cell biology of ureter development</article-title>. <source/>J Am Soc Nephrol. (<year>2013</year>) <volume>24</volume>:<fpage>19</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2012020127</pub-id><pub-id pub-id-type="pmid">23123402</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Jenkins</surname><given-names>D</given-names></name></person-group>
<article-title>Development of the kidney</article-title>. In: <source/>Heptinstall's Pathology of the Kidney. <edition>7th ed</edition>
<person-group person-group-type="editor"><name><surname>Jennette</surname><given-names>JC</given-names></name><name><surname>Olson</surname><given-names>JL</given-names></name><name><surname>Silva</surname><given-names>FG</given-names></name><name><surname>D'Agati</surname><given-names>VD</given-names></name></person-group> editors. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Wolters Kluwer</publisher-name> (<year>2015</year>). p <fpage>67</fpage>–<lpage>89</lpage>.</mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group>. <article-title>Development of the mammalian kidney</article-title>. <source/>Curr Top Dev Biol. (<year>2016</year>) <volume>117</volume>:<fpage>31</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.10.010</pub-id><pub-id pub-id-type="pmid">26969971</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolaou</surname><given-names>N</given-names></name><name><surname>Renkema</surname><given-names>KY</given-names></name><name><surname>Bongers</surname><given-names>EM</given-names></name><name><surname>Giles</surname><given-names>RH</given-names></name><name><surname>Knoers</surname><given-names>NV</given-names></name></person-group>. <article-title>Genetic, environmental, and epigenetic factors involved in CAKUT</article-title>. <source/>Nat Rev Nephrol. (<year>2015</year>) <volume>11</volume>:<fpage>720</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/nrneph.2015.140</pub-id><pub-id pub-id-type="pmid">26281895</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van</surname><given-names>der Ven AT</given-names></name><name><surname>Vivante</surname><given-names>A</given-names></name><name><surname>Hildebrandt</surname><given-names>F</given-names></name></person-group>
<article-title>Novel insights into the pathogenesis of monogenic congenital anomalies of the kidney and urinary tract</article-title>. <source/>J Am Soc Nephrol. (<year>2018</year>) <volume>29</volume>:<fpage>36</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2017050561</pub-id><pub-id pub-id-type="pmid">29079659</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>AS</given-names></name></person-group>. <article-title>Environmental influences on renal tract development: a focus on maternal diet and the glucocorticoid hypothesis</article-title>. <source/>Klin Padiatr. (<year>2011</year>) <volume>223</volume>(<issue>Suppl. 1</issue>):<fpage>S10</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1055/s-0030-1255876</pub-id><pub-id pub-id-type="pmid">21472672</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>LM</given-names></name><name><surname>Leung</surname><given-names>CY</given-names></name><name><surname>Tang</surname><given-names>WW</given-names></name><name><surname>Choi</surname><given-names>HL</given-names></name><name><surname>Leung</surname><given-names>YC</given-names></name><name><surname>McCaffery</surname><given-names>PJ</given-names></name><etal></etal></person-group>. <article-title>A paradoxical teratogenic mechanism for retinoic acid</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2012</year>) <volume>109</volume>:<fpage>13668</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1200872109</pub-id><pub-id pub-id-type="pmid">22869719</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groen</surname><given-names>In 't Woud S</given-names></name><name><surname>Renkema</surname><given-names>KY</given-names></name><name><surname>Schreuder</surname><given-names>MF</given-names></name><name><surname>Wijers</surname><given-names>CH</given-names></name><name><surname>van</surname><given-names>der Zanden LF</given-names></name><etal></etal></person-group>
<article-title>Maternal risk factors involved in specific congenital anomalies of the kidney and urinary tract: a case-control study</article-title>. <source/>Birth Defects Res A Clin Mol Teratol. (<year>2016</year>) <volume>106</volume>:<fpage>596</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1002/bdra.23500</pub-id><pub-id pub-id-type="pmid">27040999</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasri</surname><given-names>HZ</given-names></name><name><surname>Houde</surname><given-names>Ng K</given-names></name><name><surname>Westgate</surname><given-names>MN</given-names></name><name><surname>Hunt</surname><given-names>AT</given-names></name><name><surname>Holmes</surname><given-names>LB</given-names></name></person-group>. <article-title>Malformations among infants of mothers with insulin-dependent diabetes: Is there a recognizable pattern of abnormalities?</article-title>
<source/>Birth Defects Res. (<year>2018</year>) <volume>110</volume>:<fpage>108</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/bdr2.1155</pub-id><pub-id pub-id-type="pmid">29377640</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siffel</surname><given-names>C</given-names></name><name><surname>Correa</surname><given-names>A</given-names></name><name><surname>Amar</surname><given-names>E</given-names></name><name><surname>Bakker</surname><given-names>MK</given-names></name><name><surname>Bermejo-Sánchez</surname><given-names>E</given-names></name><name><surname>Bianca</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Bladder exstrophy: an epidemiologic study from the international clearinghouse for birth defects surveillance and research, and an overview of the literature</article-title>. <source/>Am J Med Genet C. (<year>2011</year>) <volume>157C</volume>:<fpage>321</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.30316</pub-id><pub-id pub-id-type="pmid">22002949</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taghavi</surname><given-names>K</given-names></name><name><surname>Sharpe</surname><given-names>C</given-names></name><name><surname>Stringer</surname><given-names>MD</given-names></name></person-group>. <article-title>Fetal megacystis: a systematic review</article-title>. <source/>J. Pediatr Urol. (<year>2017</year>) <volume>13</volume>:<fpage>7</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpurol.2016.09.003</pub-id><pub-id pub-id-type="pmid">27889224</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakkar</surname><given-names>D</given-names></name><name><surname>Deshpande</surname><given-names>AV</given-names></name><name><surname>Kennedy</surname><given-names>SE</given-names></name></person-group>. <article-title>Epidemiology and demography of recently diagnosed cases of posterior urethral valves</article-title>. <source/>Pediatr Res. (<year>2014</year>) <volume>76</volume>:<fpage>560</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2014.134</pub-id><pub-id pub-id-type="pmid">25198372</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>G</given-names></name><name><surname>Fletcher</surname><given-names>JT</given-names></name><name><surname>Alexander</surname><given-names>SI</given-names></name><name><surname>Craig</surname><given-names>JC</given-names></name></person-group>. <article-title>Vesicoureteral reflux</article-title>. <source/>J Am Soc Nephrol. (<year>2008</year>) <volume>19</volume>:<fpage>847</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2007020245</pub-id><pub-id pub-id-type="pmid">18322164</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Routh</surname><given-names>JC</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Retik</surname><given-names>AB</given-names></name><name><surname>Nelson</surname><given-names>CP</given-names></name></person-group>. <article-title>Contemporary epidemiology and characterization of newborn males with prune belly syndrome</article-title>. <source/>Urology. (<year>2010</year>) <volume>76</volume>:<fpage>44</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.urology.2009.12.072</pub-id><pub-id pub-id-type="pmid">20381841</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ek</surname><given-names>S</given-names></name><name><surname>Lidefeldt</surname><given-names>KJ</given-names></name><name><surname>Varricio</surname><given-names>L</given-names></name></person-group>. <article-title>Fetal hydronephrosis; prevalence, natural history and postnatal consequences in an unselected population</article-title>. <source/>Acta Obstet Gynecol Scand. (<year>2007</year>) <volume>86</volume>:<fpage>463</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1080/00016340701714802</pub-id><pub-id pub-id-type="pmid">17943467</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunn</surname><given-names>TR</given-names></name><name><surname>Mora</surname><given-names>JD</given-names></name><name><surname>Pease</surname><given-names>P</given-names></name></person-group>. <article-title>Antenatal diagnosis of urinary tract abnormalities by ultrasonography after 28 weeks' gestation: incidence and outcome</article-title>. <source/>Am J Obstet Gynecol. (<year>1995</year>) <volume>172</volume>:<fpage>479</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9378(95)90560-X</pub-id><pub-id pub-id-type="pmid">7856673</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismaili</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>M</given-names></name><name><surname>Piepsz</surname><given-names>A</given-names></name><name><surname>Wissing</surname><given-names>KM</given-names></name><name><surname>Collier</surname><given-names>F</given-names></name><name><surname>Schulman</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study</article-title>. <source/>J Pediatr. (<year>2006</year>) <volume>148</volume>:<fpage>222</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2005.09.037</pub-id><pub-id pub-id-type="pmid">16492433</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>WG</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name></person-group>
<article-title>Urofacial syndrome</article-title>. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. <source/>GeneReviews®. <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington; 2013 (updated June 7, 2018)</publisher-name>.</mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smellie</surname><given-names>J</given-names></name><name><surname>Barratt</surname><given-names>TM</given-names></name><name><surname>Chantler</surname><given-names>C</given-names></name><name><surname>Gordon</surname><given-names>I</given-names></name><name><surname>Prescod</surname><given-names>NP</given-names></name><etal></etal></person-group>. <article-title>Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial</article-title>. <source/>Lancet. (<year>2001</year>) <volume>357</volume>:<fpage>1329</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(00)04520-7</pub-id><pub-id pub-id-type="pmid">11343739</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feather</surname><given-names>SA</given-names></name><name><surname>Malcolm</surname><given-names>S</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Wright</surname><given-names>V</given-names></name><name><surname>Blaydon</surname><given-names>D</given-names></name><name><surname>Reid</surname><given-names>CJ</given-names></name><etal></etal></person-group>. <article-title>Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1</article-title>. <source/>Am J Hum Genet. (<year>2000</year>) <volume>66</volume>:<fpage>1420</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1086/302864</pub-id><pub-id pub-id-type="pmid">10739767</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanna-Cherchi</surname><given-names>S</given-names></name><name><surname>Reese</surname><given-names>A</given-names></name><name><surname>Hensle</surname><given-names>T</given-names></name><name><surname>Caridi</surname><given-names>G</given-names></name><name><surname>Izzi</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>YY</given-names></name><etal></etal></person-group>. <article-title>Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds</article-title>. <source/>J Am Soc Nephrol. (<year>2005</year>) <volume>16</volume>:<fpage>1781</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2004121034</pub-id><pub-id pub-id-type="pmid">15829711</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vats</surname><given-names>KR</given-names></name><name><surname>Ishwad</surname><given-names>C</given-names></name><name><surname>Singla</surname><given-names>I</given-names></name><name><surname>Vats</surname><given-names>A</given-names></name><name><surname>Ferrell</surname><given-names>R</given-names></name><name><surname>Ellis</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>A locus for renal malformations including vesico-ureteric reflux on chromosome 13q33–34</article-title>. <source/>J Am Soc Nephrol. (<year>2006</year>) <volume>17</volume>:<fpage>1158</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2005040404</pub-id><pub-id pub-id-type="pmid">16565260</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>PL</given-names></name><name><surname>Sanna-Cherchi</surname><given-names>S</given-names></name><name><surname>Hensle</surname><given-names>T</given-names></name><name><surname>Shapiro</surname><given-names>E</given-names></name><name><surname>Werzberger</surname><given-names>A</given-names></name><name><surname>Caridi</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13</article-title>. <source/>J Am Soc Nephrol. (<year>2009</year>) <volume>20</volume>:<fpage>1633</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2008111199</pub-id><pub-id pub-id-type="pmid">19443636</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Darlay</surname><given-names>R</given-names></name><name><surname>Charoen</surname><given-names>P</given-names></name><name><surname>Stewart</surname><given-names>A</given-names></name><name><surname>Gullett</surname><given-names>AM</given-names></name><name><surname>Lambert</surname><given-names>HJ</given-names></name><etal></etal></person-group>. <article-title>Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux</article-title>. <source/>J Am Soc Nephrol. (<year>2010</year>) <volume>21</volume>:<fpage>113</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2009060624</pub-id><pub-id pub-id-type="pmid">19959718</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darlow</surname><given-names>JM</given-names></name><name><surname>Dobson</surname><given-names>MG</given-names></name><name><surname>Darlay</surname><given-names>R</given-names></name><name><surname>Molony</surname><given-names>CM</given-names></name><name><surname>Hunziker</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>AJ</given-names></name><etal></etal></person-group>. <article-title>A new genome scan for primary nonsyndromic vesicoureteric reflux emphasizes high genetic heterogeneity and shows linkage and association with various genes already implicated in urinary tract development</article-title>. <source/>Mol Genet Genomic Med. (<year>2014</year>) <volume>2</volume>:<fpage>7</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.22</pub-id><pub-id pub-id-type="pmid">24498626</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darlow</surname><given-names>JM</given-names></name><name><surname>Darlay</surname><given-names>R</given-names></name><name><surname>Dobson</surname><given-names>MG</given-names></name><name><surname>Stewart</surname><given-names>A</given-names></name><name><surname>Charoen</surname><given-names>P</given-names></name><name><surname>Southgate</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Genome-wide linkage and association study implicates the 10q26 region as a major genetic contributor to primary nonsyndromic vesicoureteric reflux</article-title>. <source/>Sci Rep. (<year>2017</year>) <volume>7</volume>:<fpage>14595</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-15062-9</pub-id><pub-id pub-id-type="pmid">29097723</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>van</surname><given-names>Eerde AM</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Quintero-Rivera</surname><given-names>F</given-names></name><name><surname>Kulkarni</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Disruption of <italic>ROBO2</italic> is associated with congenital anomalies of kidney and urinary tract and confers risk of vesicoureteric reflux</article-title>. <source/>Am J Hum Genet. (<year>2007</year>) <volume>80</volume>:<fpage>616</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1086/512735</pub-id><pub-id pub-id-type="pmid">17357069</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertoli-Avella</surname><given-names>AM</given-names></name><name><surname>Conte</surname><given-names>ML</given-names></name><name><surname>Punzo</surname><given-names>F</given-names></name><name><surname>de</surname><given-names>Graaf BM</given-names></name><name><surname>Lama</surname><given-names>G</given-names></name><name><surname>La</surname><given-names>Manna A</given-names></name><etal></etal></person-group>. <article-title>ROBO2 gene variants are associated with familial vesicoureteral reflux</article-title>. <source/>J Am Soc Nephrol. (<year>2008</year>) <volume>19</volume>:<fpage>825</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2007060692</pub-id><pub-id pub-id-type="pmid">18235093</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grieshammer</surname><given-names>U</given-names></name><name><surname>Le</surname><given-names>Ma</given-names></name><name><surname>Plump</surname><given-names>AS</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group>. <article-title>SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site</article-title>. <source/>Dev Cell. (<year>2004</year>) <volume>6</volume>:<fpage>709</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/S1534-5807(04)00108-X</pub-id><pub-id pub-id-type="pmid">15130495</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>MG</given-names></name><name><surname>Darlow</surname><given-names>JM</given-names></name><name><surname>Hunziker</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>AJ</given-names></name><name><surname>Barton</surname><given-names>DE</given-names></name><name><surname>Puri</surname><given-names>P</given-names></name></person-group>. <article-title>Heterozygous non-synonymous ROBO2 variants are unlikely to be sufficient to cause familial vesicoureteric reflux</article-title>. <source/>Kidney Int. (<year>2013</year>) <volume>84</volume>:<fpage>327</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2013.100</pub-id><pub-id pub-id-type="pmid">23536131</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Houle</surname><given-names>AM</given-names></name><name><surname>Letendre</surname><given-names>J</given-names></name><name><surname>Richter</surname><given-names>A</given-names></name></person-group>. <article-title>RET Gly691Ser mutation is associated with primary vesicoureteral reflux in the French-Canadian population from Quebec</article-title>. <source/>Hum Mutat. (<year>2008</year>) <volume>29</volume>:<fpage>695</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20705</pub-id><pub-id pub-id-type="pmid">18273880</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darlow</surname><given-names>JM</given-names></name><name><surname>Molloy</surname><given-names>NH</given-names></name><name><surname>Green</surname><given-names>AJ</given-names></name><name><surname>Puri</surname><given-names>P</given-names></name><name><surname>Barton</surname><given-names>DE</given-names></name></person-group>. <article-title>The increased incidence of the RET p</article-title>.Gly691Ser variant in French-Canadian vesicoureteric reflux patients is not replicated by a larger study in Ireland. <source/>Hum Mutat. (<year>2009</year>) <volume>30</volume>:<fpage>E612</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21009</pub-id><pub-id pub-id-type="pmid">19306327</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Towers</surname><given-names>PR</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Hardman</surname><given-names>P</given-names></name></person-group>. <article-title>Glial cell line-derived neurotrophic factor stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells <italic>in vitro</italic></article-title>. <source/>Exp Nephrol. (<year>1998</year>) <volume>6</volume>:<fpage>337</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1159/000020541</pub-id><pub-id pub-id-type="pmid">9690097</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>XT</given-names></name><name><surname>Deng</surname><given-names>FM</given-names></name><name><surname>Hu</surname><given-names>P</given-names></name><name><surname>Liang</surname><given-names>FX</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Auerbach</surname><given-names>AB</given-names></name><etal></etal></person-group>. <article-title>Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases</article-title>. <source/>J Cell Biol. (<year>2004</year>) <volume>167</volume>:<fpage>1195</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200406025</pub-id><pub-id pub-id-type="pmid">15611339</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Lukianov</surname><given-names>S</given-names></name><name><surname>Ruiz</surname><given-names>WG</given-names></name><name><surname>Cianciolo</surname><given-names>Cosentino C</given-names></name><name><surname>Sanker</surname><given-names>S</given-names></name><name><surname>Traub</surname><given-names>LM</given-names></name><etal></etal></person-group>. <article-title>Requirement for a uroplakin 3a-like protein in the development of zebrafish pronephric tubule epithelial cell function, morphogenesis, and polarity</article-title>. <source/>PLoS ONE. (<year>2012</year>) <volume>7</volume>:<fpage>e41816</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0041816</pub-id><pub-id pub-id-type="pmid">22848617</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>D</given-names></name><name><surname>Bitner-Glindzicz</surname><given-names>M</given-names></name><name><surname>Malcolm</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>CC</given-names></name><name><surname>Allison</surname><given-names>J</given-names></name><name><surname>Winyard</surname><given-names>PJ</given-names></name><etal></etal></person-group>. <article-title>De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure</article-title>. <source/>J Am Soc Nephrol. (<year>2005</year>) <volume>16</volume>:<fpage>2141</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2004090776</pub-id><pub-id pub-id-type="pmid">15888565</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schönfelder</surname><given-names>EM</given-names></name><name><surname>Knüppel</surname><given-names>T</given-names></name><name><surname>Tasic</surname><given-names>V</given-names></name><name><surname>Miljkovic</surname><given-names>P</given-names></name><name><surname>Konrad</surname><given-names>M</given-names></name><name><surname>Wühl</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans</article-title>. <source/>Am J Kidney Dis. (<year>2006</year>) <volume>47</volume>:<fpage>1004</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2006.02.177</pub-id><pub-id pub-id-type="pmid">16731295</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palumbo</surname><given-names>P</given-names></name><name><surname>Accadia</surname><given-names>M</given-names></name><name><surname>Leone</surname><given-names>MP</given-names></name><name><surname>Palladino</surname><given-names>T</given-names></name><name><surname>Stallone</surname><given-names>R</given-names></name><name><surname>Carella</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Clinical and molecular characterization of an emerging chromosome 22q13</article-title>.31 microdeletion syndrome <source/>Am J Med Genet A. (<year>2018</year>) <volume>176</volume>:<fpage>391</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38559</pub-id><pub-id pub-id-type="pmid">29193617</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Gitlin</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>F</given-names></name><name><surname>Liang</surname><given-names>FX</given-names></name><name><surname>Atala</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>SB</given-names></name><etal></etal></person-group>. <article-title>Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity</article-title>. <source/>Kidney Int. (<year>2004</year>) <volume>66</volume>:<fpage>10</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00703.x</pub-id><pub-id pub-id-type="pmid">15200408</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gbadegesin</surname><given-names>RA</given-names></name><name><surname>Brophy</surname><given-names>PD</given-names></name><name><surname>Adeyemo</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>G</given-names></name><name><surname>Gupta</surname><given-names>IR</given-names></name><name><surname>Hains</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>TNXB mutations can cause vesicoureteral reflux</article-title>. <source/>J Am Soc Nephrol. (<year>2013</year>) <volume>24</volume>:<fpage>1313</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2012121148</pub-id><pub-id pub-id-type="pmid">23620400</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elahi</surname><given-names>S</given-names></name><name><surname>Homstad</surname><given-names>A</given-names></name><name><surname>Vaidya</surname><given-names>H</given-names></name><name><surname>Stout</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Rare variants in tenascin genes in a cohort of children with primary vesicoureteric reflux</article-title>. <source/>Pediatr Nephrol. (<year>2016</year>) <volume>31</volume>:<fpage>247</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-015-3203-6</pub-id><pub-id pub-id-type="pmid">26408188</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schalkwijk</surname><given-names>J</given-names></name><name><surname>Zweers</surname><given-names>MC</given-names></name><name><surname>Steijlen</surname><given-names>PM</given-names></name><name><surname>Dean</surname><given-names>WB</given-names></name><name><surname>Taylor</surname><given-names>G</given-names></name><name><surname>van</surname><given-names>Vlijmen IM</given-names></name><etal></etal></person-group>. <article-title>A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency</article-title>. <source/>N Engl J Med. (<year>2001</year>) <volume>345</volume>:<fpage>1167</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa002939</pub-id><pub-id pub-id-type="pmid">11642233</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stage</surname><given-names>KH</given-names></name><name><surname>Tank</surname><given-names>ES</given-names></name></person-group>. <article-title>Primary congenital bladder diverticula in boys</article-title>. <source/>Urology. (<year>1992</year>) <volume>40</volume>:<fpage>536</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/0090-4295(92)90410-X</pub-id><pub-id pub-id-type="pmid">1466108</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Sandulache</surname><given-names>R</given-names></name><name><surname>Neuhäuser-Klaus</surname><given-names>A</given-names></name><name><surname>Pretsch</surname><given-names>W</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><name><surname>Senft</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney</article-title>. <source/>Proc Natl Acad Sci USA. (<year>1996</year>) <volume>93</volume>:<fpage>13870</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">8943028</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murawski</surname><given-names>IJ</given-names></name><name><surname>Myburgh</surname><given-names>DB</given-names></name><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>IR</given-names></name></person-group>. <article-title>Vesico-ureteric reflux and urinary tract development in the Pax2 1Neu+/- mouse</article-title>. <source/>Am J Physiol Renal Physiol. (<year>2007</year>) <volume>293</volume>:<fpage>F1736</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00221.2007</pub-id><pub-id pub-id-type="pmid">17881463</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanyanusin</surname><given-names>P</given-names></name><name><surname>Schimmenti</surname><given-names>LA</given-names></name><name><surname>McNoe</surname><given-names>LA</given-names></name><name><surname>Ward</surname><given-names>TA</given-names></name><name><surname>Pierpont</surname><given-names>ME</given-names></name><name><surname>Sullivan</surname><given-names>MJ</given-names></name><etal></etal></person-group>. <article-title>Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux</article-title>. <source/>Nat Genet. (<year>1995</year>) <volume>9</volume>:<fpage>358</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/ng0495-358</pub-id><pub-id pub-id-type="pmid">7795640</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Moriniere</surname><given-names>V</given-names></name><name><surname>Knüppel</surname><given-names>T</given-names></name><name><surname>Charbit</surname><given-names>M</given-names></name><name><surname>Dusek</surname><given-names>J</given-names></name><name><surname>Ghiggeri</surname><given-names>GM</given-names></name><etal></etal></person-group>. <article-title>Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study</article-title>. <source/>J Am Soc Nephrol. (<year>2006</year>) <volume>17</volume>:<fpage>2864</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2006030277</pub-id><pub-id pub-id-type="pmid">16971658</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>KL</given-names></name><name><surname>McNoe</surname><given-names>LA</given-names></name><name><surname>French</surname><given-names>MC</given-names></name><name><surname>Guilford</surname><given-names>PJ</given-names></name><name><surname>Eccles</surname><given-names>MR</given-names></name></person-group>. <article-title>Absence of PAX2 gene mutations in patients with primary familial vesicoureteric reflux</article-title>. <source/>J Med Genet. (<year>1998</year>) <volume>35</volume>:<fpage>338</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.35.4.338</pub-id><pub-id pub-id-type="pmid">9598733</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eagle</surname><given-names>JF</given-names><suffix>Jr</suffix></name><name><surname>Barrett</surname><given-names>GS</given-names></name></person-group>. <article-title>Congenital deficiency of abdominal musculature with associated genitourinary abnormalities: a syndrome. Report of 9 cases</article-title>. <source/>Pediatrics. (<year>1950</year>) <volume>6</volume>:<fpage>721</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">14797335</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Workman</surname><given-names>SJ</given-names></name><name><surname>Kogan</surname><given-names>BA</given-names></name></person-group>. <article-title>Fetal bladder histology in posterior urethral valves and the prune belly syndrome</article-title>. <source/>J Urol. (<year>1990</year>) <volume>144</volume>:<fpage>337</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(17)39448-X</pub-id><pub-id pub-id-type="pmid">2374202</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popek</surname><given-names>EJ</given-names></name><name><surname>Tyson</surname><given-names>RW</given-names></name><name><surname>Miller</surname><given-names>GJ</given-names></name><name><surname>Caldwell</surname><given-names>SA</given-names></name></person-group>. <article-title>Prostate development in prune belly syndrome (PBS) and posterior urethral valves (PUV): etiology of PBS–lower urinary tract obstruction or primary mesenchymal defect?</article-title>
<source/>Pediatr Pathol. (<year>1991</year>) <volume>11</volume>:<fpage>1</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.3109/15513819109064739</pub-id><pub-id pub-id-type="pmid">2014185</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Thiele</surname><given-names>H</given-names></name><name><surname>Mir</surname><given-names>S</given-names></name><name><surname>Toliat</surname><given-names>MR</given-names></name><name><surname>Sozeri</surname><given-names>B</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome</article-title>. <source/>Am J Hum Genet. (<year>2011</year>) <volume>89</volume>:<fpage>668</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.10.007</pub-id><pub-id pub-id-type="pmid">22077972</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>M</given-names></name><name><surname>Motomura</surname><given-names>D</given-names></name><name><surname>Karasawa</surname><given-names>H</given-names></name><name><surname>Fujikawa</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Komiya</surname><given-names>Y</given-names></name><etal></etal></person-group>
<article-title>Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype <italic>Proc Natl Acad Sci USA</italic></article-title>. (<year>2000</year>) <volume>97</volume>:<fpage>9579</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.17.9579</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomper</surname><given-names>JK</given-names></name><name><surname>Wilhelm</surname><given-names>H</given-names></name><name><surname>Tayebati</surname><given-names>SK</given-names></name><name><surname>Asmus</surname><given-names>F</given-names></name><name><surname>Schüle</surname><given-names>R</given-names></name><name><surname>Sievert</surname><given-names>KD</given-names></name><etal></etal></person-group>. <article-title>A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor</article-title>. <source/>Neurology. (<year>2011</year>) <volume>76</volume>:<fpage>451</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31820a0a75</pub-id><pub-id pub-id-type="pmid">21282591</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richer</surname><given-names>J</given-names></name><name><surname>Milewicz</surname><given-names>DM</given-names></name><name><surname>Gow</surname><given-names>R</given-names></name><name><surname>de</surname><given-names>Nanassy J</given-names></name><name><surname>Maharajh</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>R179H mutation in ACTA2 expanding the phenotype to include prune-belly sequence and skin manifestations</article-title>. <source/>Am J Med Genet A. (<year>2012</year>) <volume>158A</volume>:<fpage>664</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35206</pub-id><pub-id pub-id-type="pmid">22302747</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorson</surname><given-names>W</given-names></name><name><surname>Diaz-Horta</surname><given-names>O</given-names></name><name><surname>Foster</surname><given-names>J</given-names><suffix>II</suffix></name><name><surname>Spiliopoulos</surname><given-names>M</given-names></name><name><surname>Quintero</surname><given-names>R</given-names></name><name><surname>Farooq</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title><italic>De novo</italic> ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis</article-title>. <source/>Hum Genet. (<year>2014</year>) <volume>133</volume>:<fpage>737</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-013-1406-0</pub-id><pub-id pub-id-type="pmid">24337657</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>J</given-names></name><name><surname>Ouled</surname><given-names>Amar Bencheikh B</given-names></name><name><surname>Hamdan</surname><given-names>FF</given-names></name><name><surname>Harrison</surname><given-names>SM</given-names></name><name><surname>Baker</surname><given-names>LA</given-names></name><name><surname>Couture</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome</article-title>. <source/>Eur J Hum Genet. (<year>2015</year>) <volume>23</volume>:<fpage>1266</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2014.256</pub-id><pub-id pub-id-type="pmid">25407000</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halim</surname><given-names>D</given-names></name><name><surname>Brosens</surname><given-names>E</given-names></name><name><surname>Muller</surname><given-names>F</given-names></name><name><surname>Wangler</surname><given-names>MF</given-names></name><name><surname>Beaudet</surname><given-names>AL</given-names></name><name><surname>Lupski</surname><given-names>JR</given-names></name><etal></etal></person-group>. <article-title>Loss-of-function variants in MYLK cause recessive megacystis microcolon intestinal hypoperistalsis syndrome</article-title>. <source/>Am J Hum Genet. (<year>2017</year>) <volume>101</volume>:<fpage>123</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.05.011</pub-id><pub-id pub-id-type="pmid">28602422</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caubit</surname><given-names>X</given-names></name><name><surname>Lye</surname><given-names>CM</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Core</surname><given-names>N</given-names></name><name><surname>Long</surname><given-names>DA</given-names></name><name><surname>Vola</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Teashirt 3 is necessary for ureteral smooth muscle differentiation downstream of SHH and BMP4</article-title>. <source/>Development. (<year>2008</year>) <volume>135</volume>:<fpage>3301</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1242/dev.022442</pub-id><pub-id pub-id-type="pmid">18776146</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lye</surname><given-names>CM</given-names></name><name><surname>Fasano</surname><given-names>L</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name></person-group>. <article-title>Ureter myogenesis: putting Teashirt into context</article-title>. <source/>J Am Soc Nephrol. (<year>2010</year>) <volume>21</volume>:<fpage>24</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2008111206</pub-id><pub-id pub-id-type="pmid">19926888</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Garcia-Barrio</surname><given-names>MT</given-names></name><name><surname>Rom</surname><given-names>O</given-names></name><name><surname>Ma</surname><given-names>PX</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Direct reprogramming of fibroblasts into smooth muscle-like cells with defined transcription factors- brief report</article-title>. <source/>Arterioscler Thromb Vasc Biol. (<year>2018</year>) <volume>38</volume>:<fpage>2191</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.118.310870</pub-id><pub-id pub-id-type="pmid">30026272</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boghossian</surname><given-names>NS</given-names></name><name><surname>Sicko</surname><given-names>RJ</given-names></name><name><surname>Giannakou</surname><given-names>A</given-names></name><name><surname>Dimopoulos</surname><given-names>A</given-names></name><name><surname>Caggana</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>MY</given-names></name><etal></etal></person-group>. <article-title>Rare copy number variants identified in prune belly syndrome</article-title>. <source/>Eur J Med Genet. (<year>2018</year>) <volume>61</volume>:<fpage>145</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2017.11.008</pub-id><pub-id pub-id-type="pmid">29174092</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeri</surname><given-names>S Devers PL</given-names></name><name><surname>Kaiser-Rogers</surname><given-names>KA</given-names></name><name><surname>Moylan</surname><given-names>VJ</given-names><suffix>Jr</suffix></name><name><surname>Torchia</surname><given-names>BS</given-names></name><name><surname>Horton</surname><given-names>AL</given-names></name><name><surname>Wolfe</surname><given-names>HM</given-names></name><name><surname>Aylsworth</surname><given-names>AS</given-names></name></person-group>. <article-title>Deletion of hepatocyte nuclear factor-1-beta in an infant with prune belly syndrome</article-title>. <source/>Am J Perinatol. (<year>2010</year>) <volume>27</volume>:<fpage>559</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1055/s-0030-1248943</pub-id><pub-id pub-id-type="pmid">20175044</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolatsi-Joannou</surname><given-names>M</given-names></name><name><surname>Bingham</surname><given-names>C</given-names></name><name><surname>Ellard</surname><given-names>S</given-names></name><name><surname>Bulman</surname><given-names>MP</given-names></name><name><surname>Allen</surname><given-names>LIS</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><etal></etal></person-group>. <article-title>Hepatocyte nuclear factor 1β: a new kindred with renal cysts and diabetes, and gene expression in normal human development</article-title>. <source/>J Am Soc Nephrol. (<year>2001</year>) <volume>12</volume>:<fpage>2175</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">11562418</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adalat</surname><given-names>S</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Johnstone</surname><given-names>KA</given-names></name><name><surname>Wirsing</surname><given-names>A</given-names></name><name><surname>Harries</surname><given-names>LW</given-names></name><name><surname>Long</surname><given-names>DA</given-names></name><etal></etal></person-group>
<article-title><italic>Hepatocyte Nuclear Factor 1B</italic> mutations associate with hypomagnesemia and renal magnesium wasting</article-title>. <source/>J Am Soc Nephrol. (<year>2009</year>) <volume>20</volume>:<fpage>1123</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2008060633</pub-id><pub-id pub-id-type="pmid">19389850</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granberg</surname><given-names>CF</given-names></name><name><surname>Harrison</surname><given-names>SM</given-names></name><name><surname>Dajusta</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Hajarnis</surname><given-names>S</given-names></name><name><surname>Igarashi</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>Genetic basis of prune belly syndrome: screening for HNF1β gene</article-title>. <source/>J Urol. (<year>2012</year>) <volume>187</volume>:<fpage>272</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2011.09.036</pub-id><pub-id pub-id-type="pmid">22114815</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochoa</surname><given-names>B</given-names></name></person-group>. <article-title>Can a congenital dysfunctional bladder be diagnosed from a smile?</article-title> The Ochoa syndrome updated. <source/>Pediatr Nephrol. (<year>2004</year>) <volume>19</volume>:<fpage>6</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-003-1291-1</pub-id><pub-id pub-id-type="pmid">14648341</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daly</surname><given-names>SB</given-names></name><name><surname>Urquhart</surname><given-names>JE</given-names></name><name><surname>Hilton</surname><given-names>E</given-names></name><name><surname>McKenzie</surname><given-names>EA</given-names></name><name><surname>Kammerer</surname><given-names>RA</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Mutations in <italic>HPSE2</italic> cause urofacial syndrome</article-title>. <source/>Am J Hum Genet. (<year>2010</year>) <volume>11</volume>:<fpage>963</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.07.010</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Hawkins-Lee</surname><given-names>B</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome</article-title>. <source/>Am J Hum Genet. (<year>2010</year>) <volume>86</volume>:<fpage>957</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.06.014</pub-id><pub-id pub-id-type="pmid">20560209</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>HM</given-names></name><name><surname>Roberts</surname><given-names>NA</given-names></name><name><surname>Hilton</surname><given-names>EN</given-names></name><name><surname>McKenzie</surname><given-names>EA</given-names></name><name><surname>Daly</surname><given-names>SB</given-names></name><name><surname>Hadfield</surname><given-names>KD</given-names></name><etal></etal></person-group>. <article-title>Urinary tract effects of <italic>HPSE2</italic> mutations</article-title>. <source/>J Am Soc Nephrol. (<publisher-loc>2015</publisher-loc>) <volume>26</volume>:<fpage>797</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2013090961</pub-id><pub-id pub-id-type="pmid">25145936</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>S</given-names></name><name><surname>Beetz</surname><given-names>C</given-names></name><name><surname>Tahir</surname><given-names>MM</given-names></name><name><surname>Imran</surname><given-names>M</given-names></name><name><surname>Mumtaz</surname><given-names>R</given-names></name><name><surname>Bassmann</surname><given-names>I</given-names></name><etal></etal></person-group>. <article-title>First HPSE2 missense mutation in urofacial syndrome</article-title>. <source/>Clin Genet. (<year>2012</year>) <volume>81</volume>:<fpage>88</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01649.x</pub-id><pub-id pub-id-type="pmid">21332471</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivante</surname><given-names>A</given-names></name><name><surname>Hwang</surname><given-names>DY</given-names></name><name><surname>Kohl</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Shril</surname><given-names>S</given-names></name><name><surname>Schulz</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Exome sequencing discerns syndromes in patients from consanguineous families with congenital anomalies of the Kidneys and urinary tract</article-title>. <source/>J Am Soc Nephrol. (<year>2017</year>) <volume>28</volume>:<fpage>69</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2015080962</pub-id><pub-id pub-id-type="pmid">27151922</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Levy-Adam</surname><given-names>F</given-names></name><name><surname>Feld</surname><given-names>S</given-names></name><name><surname>Cohen-Kaplan</surname><given-names>V</given-names></name><name><surname>Shteingauz</surname><given-names>A</given-names></name><name><surname>Gross</surname><given-names>M</given-names></name><name><surname>Arvatz</surname><given-names>G</given-names></name><name><surname>Naroditsky</surname><given-names>I</given-names></name><name><surname>Ilan</surname><given-names>N</given-names></name><name><surname>Doweck</surname><given-names>I</given-names></name><name><surname>Vlodavsky</surname><given-names>I</given-names></name></person-group>. <article-title>Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity</article-title>. <source/>J Biol Chem. (<publisher-loc>2010</publisher-loc>) <volume>285</volume>:<fpage>28010</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.116384</pub-id><pub-id pub-id-type="pmid">20576607</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>HM</given-names></name><name><surname>Roberts</surname><given-names>NA</given-names></name><name><surname>Bergu</surname><given-names>B</given-names></name><name><surname>Daly</surname><given-names>SB</given-names></name><name><surname>Urquhart</surname><given-names>JE</given-names></name><name><surname>Bhaskar</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title><italic>LRIG2</italic> mutations cause urofacial syndrome</article-title>. <source/>Am J Hum Genet. (<year>2013</year>) <volume>92</volume>:<fpage>259</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.002</pub-id><pub-id pub-id-type="pmid">23313374</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadda</surname><given-names>A</given-names></name><name><surname>Butt</surname><given-names>F</given-names></name><name><surname>Tomei</surname><given-names>S</given-names></name><name><surname>Deola</surname><given-names>S</given-names></name><name><surname>Lo</surname><given-names>B</given-names></name><name><surname>Robay</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotype</article-title>. <source/>BMC Med Genet. (<year>2016</year>) <volume>17</volume>:<fpage>84</fpage>. <pub-id pub-id-type="doi">10.1186/s12881-016-0346-7</pub-id><pub-id pub-id-type="pmid">27855655</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>NA</given-names></name><name><surname>Hilton</surname><given-names>EN</given-names></name><name><surname>Lopes</surname><given-names>FM</given-names></name><name><surname>Randles</surname><given-names>MJ</given-names></name><name><surname>Sigh</surname><given-names>S</given-names></name><name><surname>Gardiner</surname><given-names>NJ</given-names></name><etal></etal></person-group>. <article-title>Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder</article-title>. <source/>Kidney Int. (<year>2019</year>). <pub-id pub-id-type="doi">10.1016/j.kint.2018.11.040</pub-id>. [Epub ahead of print].<pub-id pub-id-type="pmid">30885509</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>F</given-names></name><name><surname>Mao</surname><given-names>F</given-names></name><name><surname>Zong</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells <italic>in vitro</italic> and <italic>in vivo</italic> through enhancing PDGFRβ signaling</article-title>. <source/>Int J Oncol. (<year>2018</year>) <volume>53</volume>:<fpage>1069</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.2018.4482</pub-id><pub-id pub-id-type="pmid">30015847</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simion</surname><given-names>C</given-names></name><name><surname>Cedano-Prieto</surname><given-names>ME</given-names></name><name><surname>Sweeney</surname><given-names>C</given-names></name></person-group>. <article-title>The LRIG family: enigmatic regulators of growth factor receptor signaling</article-title>. <source/>Endocr Relat Cancer. (<year>2014</year>) <volume>21</volume>:<fpage>R431</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1530/ERC-14-0179</pub-id><pub-id pub-id-type="pmid">25183430</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>NA</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Stuart</surname><given-names>HM</given-names></name><name><surname>Thuret</surname><given-names>R</given-names></name><name><surname>McKenzie</surname><given-names>EA</given-names></name><name><surname>Newman</surname><given-names>WG</given-names></name><etal></etal></person-group>. <article-title>Heparanase 2, mutated in urofacial syndrome, mediates peripheral neural development in Xenopus</article-title>. <source/>Hum Mol Genet. (<year>2014</year>) <volume>23</volume>:<fpage>4302</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu147</pub-id><pub-id pub-id-type="pmid">24691552</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Kaneko</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Vlodavsky</surname><given-names>I</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>A mouse model of urofacial syndrome with dysfunctional urination</article-title>. <source/>Hum Mol Genet. (<publisher-loc>2015</publisher-loc>) <volume>24</volume>:<fpage>1991</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu613</pub-id><pub-id pub-id-type="pmid">25510506</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnett</surname><given-names>AL</given-names></name><name><surname>Calvin</surname><given-names>DC</given-names></name><name><surname>Chamness</surname><given-names>SL</given-names></name><name><surname>Liu</surname><given-names>JX</given-names></name><name><surname>Nelson</surname><given-names>RJ</given-names></name><name><surname>Klein</surname><given-names>SL</given-names></name><etal></etal></person-group>. <article-title>Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans</article-title>. <source/>Nat Med. (<year>1997</year>) <volume>3</volume>:<fpage>571</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/nm0597-571</pub-id><pub-id pub-id-type="pmid">9142130</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Caubit</surname><given-names>X</given-names></name><name><surname>Airik</surname><given-names>R</given-names></name><name><surname>Vola</surname><given-names>C</given-names></name><name><surname>Fatmi</surname><given-names>A</given-names></name><name><surname>Kispert</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>TSHZ3 and SOX9 regulate the timing of smooth muscle cell differentiation in the ureter by reducing myocardin activity</article-title>. <source/>PLoS ONE. (<year>2013</year>) <volume>8</volume>:<fpage>e63721</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0063721</pub-id><pub-id pub-id-type="pmid">23671695</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>D</given-names></name><name><surname>Caubit</surname><given-names>X</given-names></name><name><surname>Dimovski</surname><given-names>A</given-names></name><name><surname>Matevska</surname><given-names>N</given-names></name><name><surname>Lye</surname><given-names>CM</given-names></name><name><surname>Cabuk</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>Analysis of <italic>TSHZ2</italic> and <italic>TSHZ3</italic> genes in congenital pelvi-ureteric junction obstruction</article-title>. <source/>Nephrol Dial Transplant. (<year>2010</year>) <volume>25</volume>:<fpage>54</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfp453</pub-id><pub-id pub-id-type="pmid">19745106</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caubit</surname><given-names>X</given-names></name><name><surname>Gubellini</surname><given-names>P</given-names></name><name><surname>Andrieux</surname><given-names>J</given-names></name><name><surname>Roubertoux</surname><given-names>P</given-names></name><name><surname>Metwaly</surname><given-names>M</given-names></name><name><surname>Jacq</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title><italic>TSHZ3</italic> deletion causes an autism syndrome and defects in cortical projection neurons</article-title>. <source/>Nature Genet. (<year>2016</year>) <volume>48</volume>:<fpage>1359</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3681</pub-id><pub-id pub-id-type="pmid">27668656</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Südbeck</surname><given-names>P</given-names></name><name><surname>Schmitz</surname><given-names>ML</given-names></name><name><surname>Baeuerle</surname><given-names>PA</given-names></name><name><surname>Scherer</surname><given-names>G</given-names></name></person-group>. <article-title>Sex reversal by loss of the C-terminal transactivation domain of human SOX9</article-title>. <source/>Nat Genet. (<year>1996</year>) <volume>13</volume>:<fpage>230</fpage>–<lpage>2</lpage>.<pub-id pub-id-type="pmid">8640233</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Houston</surname><given-names>CS</given-names></name><name><surname>Opitz</surname><given-names>JM</given-names></name><name><surname>Spranger</surname><given-names>JW</given-names></name><name><surname>Macpherson</surname><given-names>RI</given-names></name><name><surname>Reed</surname><given-names>MH</given-names></name><name><surname>Gilbert</surname><given-names>EF</given-names></name><etal></etal></person-group>. <article-title>The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971</article-title>. <source/>Am J Med Genet. (<publisher-loc>1983</publisher-loc>) <volume>15</volume>:<fpage>3</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320150103</pub-id><pub-id pub-id-type="pmid">6344634</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohnenpoll</surname><given-names>T</given-names></name><name><surname>Bettenhausen</surname><given-names>E</given-names></name><name><surname>Weiss</surname><given-names>AC</given-names></name><name><surname>Foik</surname><given-names>AB</given-names></name><name><surname>Trowe</surname><given-names>MO</given-names></name><name><surname>Blank</surname><given-names>P</given-names></name><etal></etal></person-group>. <article-title>Tbx18 expression demarcates multipotent precursor populations in the developing urogenital system but is exclusively required within the ureteric mesenchymal lineage to suppress a renal stromal fate</article-title>. <source/>Dev Biol. (<year>2013</year>) <volume>380</volume>:<fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2013.04.036</pub-id><pub-id pub-id-type="pmid">23685333</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vivante</surname><given-names>A</given-names></name><name><surname>Kleppa</surname><given-names>MJ</given-names></name><name><surname>Schulz</surname><given-names>J</given-names></name><name><surname>Kohl</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Mutations in <italic>TBX18</italic> cause dominant urinary tract malformations <italic>via</italic> transcriptional dysregulation of ureter development</article-title>. <source/>Am J Hum Genet. (<publisher-loc>2015</publisher-loc>) <volume>97</volume>:<fpage>291</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.07.001</pub-id><pub-id pub-id-type="pmid">26235987</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>YJ</given-names></name><name><surname>Lin</surname><given-names>YZ</given-names></name><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>ZY</given-names></name></person-group>. <article-title>Transcription factor Tbx18 induces the differentiation of c-kit<sup>+</sup> canine mesenchymal stem cells (cMSCs) into SAN-like pacemaker cells in a co-culture model <italic>in vitro</italic></article-title>. <source/>Am J Transl Res. (<year>2018</year>) <volume>10</volume>:<fpage>2511</fpage>–<lpage>28</lpage>.<pub-id pub-id-type="pmid">30210689</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiaramonte</surname><given-names>C</given-names></name><name><surname>Bommarito</surname><given-names>D</given-names></name><name><surname>Zambaiti</surname><given-names>E</given-names></name><name><surname>Antona</surname><given-names>V</given-names></name><name><surname>Li Voti</surname><given-names>G</given-names></name></person-group>. <article-title>Genetic basis of posterior urethral valves inheritance</article-title>. <source/>Urology. (<year>2016</year>) <volume>95</volume>:<fpage>175</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.urology.2016.05.043</pub-id><pub-id pub-id-type="pmid">27261184</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frese</surname><given-names>S</given-names></name><name><surname>Weigert</surname><given-names>A</given-names></name><name><surname>Hoppe</surname><given-names>B</given-names></name><name><surname>Feldkötter</surname><given-names>M</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>A classic twin study of lower urinary tract obstruction: report of 3 cases and literature review</article-title>. <source/>Low Urin Tract Symptoms. (<year>2018</year>). <pub-id pub-id-type="doi">10.1111/luts.12222</pub-id>. [Epub ahead of print].<pub-id pub-id-type="pmid">29664229</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boghossian</surname><given-names>NS</given-names></name><name><surname>Sicko</surname><given-names>RJ</given-names></name><name><surname>Kay</surname><given-names>DM</given-names></name><name><surname>Rigler</surname><given-names>SL</given-names></name><name><surname>Caggana</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>MY</given-names></name><etal></etal></person-group>. <article-title>Rare copy number variants implicated in posterior urethral valves</article-title>. <source/>Am J Med Genet A. (<year>2016</year>) <volume>170</volume>:<fpage>622</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37493</pub-id><pub-id pub-id-type="pmid">26663319</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faure</surname><given-names>A</given-names></name><name><surname>Bouty</surname><given-names>A</given-names></name><name><surname>Caruana</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>L</given-names></name><name><surname>Burgess</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>MN</given-names></name><etal></etal></person-group>. <article-title>DNA copy number variants: a potentially useful predictor of early onset renal failure in boys with posterior urethral valves</article-title>. <source/>J Pediatr Urol. (<year>2016</year>) <volume>12</volume>:<fpage>227</fpage>.<lpage>e1–7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpurol.2016.02.020</pub-id><pub-id pub-id-type="pmid">27160979</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolvenbach</surname><given-names>CM</given-names></name><name><surname>Frese</surname><given-names>SK</given-names></name><name><surname>Dworschak</surname><given-names>GC</given-names></name><name><surname>Japp</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>JM</given-names></name><name><surname>Zaniew</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Mutations in BNC2 lead to autosomal-dominant lower urinary tract obstruction (LUTO)</article-title>. <source/>Pediatr Nephrol. (<year>2018</year>) <volume>33</volume>:<fpage>1809</fpage>–<lpage>10</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://espn2018.org/abstracts/abstract.php?bid=146">https://espn2018.org/abstracts/abstract.php?bid=146</ext-link></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhoj</surname><given-names>EJ</given-names></name><name><surname>Ramos</surname><given-names>P</given-names></name><name><surname>Baker</surname><given-names>LA</given-names></name><name><surname>Garg</surname><given-names>V</given-names></name><name><surname>Cost</surname><given-names>N</given-names></name><name><surname>Nordenskjöld</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Human balanced translocation and mouse gene inactivation implicate Basonuclin 2 in distal urethral development</article-title>. <source/>Eur J Hum Genet. (<year>2011</year>) <volume>19</volume>:<fpage>540</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2010.245</pub-id><pub-id pub-id-type="pmid">21368915</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Knapp</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Kajioka</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>JM</given-names></name><name><surname>Winkler</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract development</article-title>. <source/>Sci Rep. (<year>2017</year>) <volume>7</volume>:<fpage>42170</fpage>. <pub-id pub-id-type="doi">10.1038/srep42170</pub-id><pub-id pub-id-type="pmid">28176844</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arkani</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Lundin</surname><given-names>J</given-names></name><name><surname>Nilsson</surname><given-names>D</given-names></name><name><surname>Källman</surname><given-names>T</given-names></name><name><surname>Barker</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Evaluation of the <italic>ISL1</italic> gene in the pathogenesis of bladder exstrophy in a Swedish cohort</article-title>. <source/>Hum Genome Var. (<year>2018</year>) <volume>5</volume>:<fpage>18009</fpage>. <pub-id pub-id-type="doi">10.1038/hgv.2018.9</pub-id><pub-id pub-id-type="pmid">29619236</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Knapp</surname><given-names>M</given-names></name><name><surname>Kause</surname><given-names>F</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name></person-group>. <article-title>Role of the LF-SINE-derived distal <italic>ISL1</italic> enhancer in patients with classic bladder exstrophy</article-title>. <source/>J Pediatr Genet. (<year>2017</year>) <volume>6</volume>:<fpage>169</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1055/s-0037-1602387</pub-id><pub-id pub-id-type="pmid">28794909</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ching</surname><given-names>ST</given-names></name><name><surname>Infante</surname><given-names>CR</given-names></name><name><surname>Du</surname><given-names>W</given-names></name><name><surname>Sharir</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Menke</surname><given-names>DB</given-names></name><etal></etal></person-group>. <article-title>Isl1 mediates mesenchymal expansion in the developing external genitalia via regulation of Bmp4, Fgf10 and Wnt5a</article-title>. <source/>Hum Mol Genet. (<year>2018</year>) <volume>27</volume>:<fpage>107</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx388</pub-id><pub-id pub-id-type="pmid">29126155</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>D</given-names></name><name><surname>Winyard</surname><given-names>PJD</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name></person-group>. <article-title>Immunohistochemical analysis of sonic hedgehog signalling in normal human urinary tract development</article-title>. <source/>J Anat. (<year>2007</year>) <volume>211</volume>:<fpage>620</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7580.2007.00808.x</pub-id><pub-id pub-id-type="pmid">17850284</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draaken</surname><given-names>M</given-names></name><name><surname>Reutter</surname><given-names>H</given-names></name><name><surname>Schramm</surname><given-names>C</given-names></name><name><surname>Bartels</surname><given-names>E</given-names></name><name><surname>Boemers</surname><given-names>TM</given-names></name><name><surname>Ebert</surname><given-names>AK</given-names></name><etal></etal></person-group>. <article-title>Microduplications at 22q11</article-title>.21 are associated with non-syndromic classic bladder exstrophy. <source/>Eur J Med Genet. (<year>2010</year>) <volume>53</volume>:<fpage>55</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2009.12.005</pub-id><pub-id pub-id-type="pmid">20060941</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draaken</surname><given-names>M</given-names></name><name><surname>Baudisch</surname><given-names>F</given-names></name><name><surname>Timmermann</surname><given-names>B</given-names></name><name><surname>Kuhl</surname><given-names>H</given-names></name><name><surname>Kerick</surname><given-names>M</given-names></name><name><surname>Proske</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Classic bladder exstrophy: Frequent 22q11.21 duplications and definition of a 414 kb phenocritical region</article-title>. <source/>Birth Defects Res A Clin Mol Teratol. (<year>2014</year>) <volume>100</volume>:<fpage>512</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/bdra.23249</pub-id><pub-id pub-id-type="pmid">24764164</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaman</surname><given-names>GM</given-names></name><name><surname>Woolf</surname><given-names>AS</given-names></name><name><surname>Cervellione</surname><given-names>RM</given-names></name><name><surname>Keene</surname><given-names>D</given-names></name><name><surname>Mushtaq</surname><given-names>I</given-names></name><name><surname>Urquhart</surname><given-names>JE</given-names></name><etal></etal></person-group>. <article-title>22q11</article-title>.2 duplications in a UK cohort with bladder exstrophy-epispadias complex. <source/>Am J Med Genet A. (<year>2019</year>) <volume>179</volume>:<fpage>404</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.61032</pub-id><pub-id pub-id-type="pmid">30628148</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Rivera</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>YP</given-names></name><name><surname>Verbitsky</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>BR</given-names></name><name><surname>Capone</surname><given-names>VP</given-names></name><name><surname>Otto</surname><given-names>EA</given-names></name><etal></etal></person-group>. <article-title>Genetic drivers of kidney defects in the DiGeorge syndrome</article-title>. <source/>N Engl J Med. (<year>2017</year>) <volume>376</volume>:<fpage>742</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1609009</pub-id><pub-id pub-id-type="pmid">28121514</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groopman</surname><given-names>EE</given-names></name><name><surname>Marasa</surname><given-names>M</given-names></name><name><surname>Cameron-Christie</surname><given-names>S</given-names></name><name><surname>Petrovski</surname><given-names>S</given-names></name><name><surname>Aggarwal</surname><given-names>VS</given-names></name><name><surname>Milo-Rasouly</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Diagnostic utility of exome sequencing for kidney disease</article-title>. <source/>N Engl J Med. (<year>2019</year>) <volume>380</volume>:<fpage>142</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1806891</pub-id><pub-id pub-id-type="pmid">30586318</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van</surname><given-names>der Ven AT</given-names></name><name><surname>Connaughton</surname><given-names>DM</given-names></name><name><surname>Ityel</surname><given-names>H</given-names></name><name><surname>Mann</surname><given-names>N</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract</article-title>. <source/>J Am Soc Nephrol. (<year>2018</year>) <volume>29</volume>:<fpage>2348</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2017121265</pub-id><pub-id pub-id-type="pmid">30143558</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>J</given-names></name><name><surname>Akbarov</surname><given-names>A</given-names></name><name><surname>Eales</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Dormer</surname><given-names>JP</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Denniff</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Uncovering genetic mechanisms of kidney aging through transcriptomics, genomics, and epigenomics</article-title>. <source/>Kidney Int. (<year>2019</year>) <volume>95</volume>:<fpage>624</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2018.10.029</pub-id><pub-id pub-id-type="pmid">30784661</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal></etal></person-group>. <article-title>Genomic and epigenomic analyses of monozygotic twins discordant for congenital renal agenesis</article-title>. <source/>Am J Kidney Dis. (<publisher-loc>2014</publisher-loc>) <volume>64</volume>:<fpage>119</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2014.01.423</pub-id><pub-id pub-id-type="pmid">24583054</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendell</surname><given-names>JR</given-names></name><name><surname>Al-Zaidy</surname><given-names>S</given-names></name><name><surname>Shell</surname><given-names>R</given-names></name><name><surname>Arnold</surname><given-names>WD</given-names></name><name><surname>Rodino-Klapac</surname><given-names>LR</given-names></name><name><surname>Prior</surname><given-names>TW</given-names></name><etal></etal></person-group>. <article-title>single-dose gene-replacement therapy for spinal muscular atrophy</article-title>. <source/>N Engl J Med. (<year>2007</year>) <volume>377</volume>:<fpage>1713</fpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1706198</pub-id><pub-id pub-id-type="pmid">29091557</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picconi</surname><given-names>JL</given-names></name><name><surname>Muff-Luett</surname><given-names>MA</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Bunchman</surname><given-names>E</given-names></name><name><surname>Schaefer</surname><given-names>F</given-names></name><name><surname>Brophy</surname><given-names>PD</given-names></name></person-group>. <article-title>Kidney-specific expression of GFP by in-utero delivery of pseudotyped adeno-associated virus 9</article-title>. <source/>Mol Ther Methods Clin Dev. (<year>2015</year>) <volume>1</volume>:<fpage>14014</fpage>. <pub-id pub-id-type="doi">10.1038/mtm.2014.14</pub-id><pub-id pub-id-type="pmid">26015958</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karda</surname><given-names>R</given-names></name><name><surname>Buckley</surname><given-names>SM</given-names></name><name><surname>Mattar</surname><given-names>CN</given-names></name><name><surname>Ng</surname><given-names>J</given-names></name><name><surname>Massaro</surname><given-names>G</given-names></name><name><surname>Hughes</surname><given-names>MP</given-names></name><name><surname>Kurian</surname><given-names>MA</given-names></name><etal></etal></person-group>. <article-title>Perinatal systemic gene delivery using adeno-associated viral vectors</article-title>. <source/>Front Mol Neurosci. (<year>2014</year>) <volume>7</volume>:<fpage>89</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2014.00089</pub-id><pub-id pub-id-type="pmid">25452713</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattar</surname><given-names>CN</given-names></name><name><surname>Wong</surname><given-names>AM</given-names></name><name><surname>Hoefer</surname><given-names>K</given-names></name><name><surname>Alonso-Ferrero</surname><given-names>ME</given-names></name><name><surname>Buckley</surname><given-names>SM</given-names></name><name><surname>Howe</surname><given-names>SJ</given-names></name><etal></etal></person-group>. <article-title>Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates</article-title>. <source/>FASEB J. (<year>2015</year>) <volume>29</volume>:<fpage>3876</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1096/fj.14-269092</pub-id><pub-id pub-id-type="pmid">26062602</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckinx</surname><given-names>R</given-names></name><name><surname>Van</surname><given-names>Remoortel S</given-names></name><name><surname>Gijsbers</surname><given-names>R</given-names></name><name><surname>Waddington</surname><given-names>SN</given-names></name><name><surname>Timmermans</surname><given-names>JP</given-names></name></person-group>. <article-title>Proof-of-concept: neonatal intravenous injection of adeno-associated virus vectors results in successful transduction of myenteric and submucosal neurons in the mouse small and large intestine</article-title>. <source/>Neurogastroenterol Motil. (<year>2016</year>) <volume>28</volume>:<fpage>299</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1111/nmo.12724</pub-id><pub-id pub-id-type="pmid">26564813</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>